CytoSorbents Corporation

7 Deer Park Drive, Suite K
Monmouth Junction, NJ 08852 USA
Click for website

Research Sector Medical Devices

Summary Description Develops blood purification technology to actively remove toxic substances from blood and other bodily fluids.

Management Phillip P. Chan, MD, PhD, Chief Executive Officer; Vincent Capponi, Chief Operating Officer; David Lamadrid, MBA, Chief Financial Officer; Robert Bartlett, M.D., Chief Medical Officer

Click here for Financial Data
Keywords: blood purification, cytokine, cytokine storm, infectious disease, life-threatening illnesses, hemoperfusion, dialysis, hemofiltration


Updated: Feb. 21, 2017


CytoSorbents has developed hemoperfusion technology to treat conditions such as sepsis and kidney disease by removing toxins and deleterious components from the blood. Sepsis can occur when the immune......view more

Technology / Differentiation

CytoSorb acts by reducing the level of cytokines, which trigger dangerous inflammation and immune system responses. Through the reduction of inflammatory mediators, the odds of recovery should be sign...view more


The company holds 25 patents in the U.S., some of which have foreign counterparts and additional patent applications pending worldwide, some of which have foreign counterparts. The patents cover mater...view more